Stephen Calabro

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

Steven A. Rosenberg, Michael T. Lotze, Jiacai Yang et al. · Journal of Clinical Oncology · 1989 · 379 citations

Pharmacy, Oncology, Pharmacotherapy +17

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis

Robert E. Kalb, David Fiorentino, Mark Lebwohl et al. · JAMA Dermatology · 2015 · 372 citations

Medicine, Dermatology, Pharmacotherapy +17

Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Alan Menter, Kim Papp, Melinda Gooderham et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 242 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +17

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR)

Alexa B. Kimball, C. Leonardi, Mona Ståhle et al. · British Journal of Dermatology · 2014 · 115 citations · Full text

Public Health, Demography, Dermatology +11

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Bruce Strober, Robert Bissonnette, David Fiorentino et al. · Journal of the American Academy of Dermatology · 2016 · 86 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15